Ashland Inc. (ASH)
NYSE: ASH · Real-Time Price · USD
56.15
+0.38 (0.67%)
Aug 29, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
Life Sciences | 810.00M | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences Growth | -19.51% | Log In | Log In | Log In | Log In | Upgrade |
Personal Care | 634.00M | Log In | Log In | Log In | Log In | Upgrade |
Personal Care Growth | -4.85% | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives | 572.00M | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives Growth | -8.55% | Log In | Log In | Log In | Log In | Upgrade |
Intermediates | 144.00M | Log In | Log In | Log In | Log In | Upgrade |
Intermediates Growth | -4.79% | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from | -47.00M | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Growth | -10.42% | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
Other | 197.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 585.19% | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences Operating Income | 168.00M | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences Operating Income Growth | -265.38% | Log In | Log In | Log In | Log In | Upgrade |
Personal Care Operating Income | 73.00M | Log In | Log In | Log In | Log In | Upgrade |
Personal Care Operating Income Growth | 8.33% | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives Operating Income | -32.00M | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives Operating Income Growth | 542.31% | Log In | Log In | Log In | Log In | Upgrade |
Intermediates Operating Income | 29.00M | Log In | Log In | Log In | Log In | Upgrade |
Intermediates Operating Income Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 197.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 585.19% | Log In | Log In | Log In | Log In | Upgrade |
Unallocated and Other Operating Income | -264.00M | Log In | Log In | Log In | Log In | Upgrade |
Unallocated and Other Operating Income Growth | 13.91% | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
Life Sciences EBITDA | 229.00M | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences EBITDA Growth | -11.76% | Log In | Log In | Log In | Log In | Upgrade |
Personal Care EBITDA | 152.00M | Log In | Log In | Log In | Log In | Upgrade |
Personal Care EBITDA Growth | -3.90% | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives EBITDA | 89.00M | Log In | Log In | Log In | Log In | Upgrade |
Specialty Additives EBITDA Growth | 10.13% | Log In | Log In | Log In | Log In | Upgrade |
Intermediates EBITDA | 42.00M | Log In | Log In | Log In | Log In | Upgrade |
Intermediates EBITDA Growth | -23.53% | Log In | Log In | Log In | Log In | Upgrade |
Unallocated and Other EBITDA | -264.00M | Log In | Log In | Log In | Log In | Upgrade |
Unallocated and Other EBITDA Growth | 13.91% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
United States | 624.00M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | - | Log In | Log In | Log In | Log In | Upgrade |
International | 1.49B | Log In | Log In | Log In | Log In | Upgrade |
International Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
Change in Sales Due to Volume | 1.00M | Log In | Log In | Log In | Log In | Upgrade |
Change in Sales Due to Volume Growth | -234.62% | Log In | Log In | Log In | Log In | Upgrade |
Change in Sales Due to Product Pricing/Mix | -78.00M | Log In | Log In | Log In | Log In | Upgrade |
Change in Sales Due to Product Pricing/Mix Growth | -54.17% | Log In | Log In | Log In | Log In | Upgrade |